1. Home
  2. WEAV vs DNTH Comparison

WEAV vs DNTH Comparison

Compare WEAV & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WEAV
  • DNTH
  • Stock Information
  • Founded
  • WEAV 2011
  • DNTH 2015
  • Country
  • WEAV United States
  • DNTH United States
  • Employees
  • WEAV N/A
  • DNTH N/A
  • Industry
  • WEAV EDP Services
  • DNTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • WEAV Technology
  • DNTH Health Care
  • Exchange
  • WEAV Nasdaq
  • DNTH Nasdaq
  • Market Cap
  • WEAV 837.7M
  • DNTH 657.0M
  • IPO Year
  • WEAV 2021
  • DNTH N/A
  • Fundamental
  • Price
  • WEAV $10.46
  • DNTH $20.62
  • Analyst Decision
  • WEAV Strong Buy
  • DNTH Strong Buy
  • Analyst Count
  • WEAV 5
  • DNTH 8
  • Target Price
  • WEAV $16.10
  • DNTH $54.33
  • AVG Volume (30 Days)
  • WEAV 665.2K
  • DNTH 291.3K
  • Earning Date
  • WEAV 05-05-2025
  • DNTH 05-16-2025
  • Dividend Yield
  • WEAV N/A
  • DNTH N/A
  • EPS Growth
  • WEAV N/A
  • DNTH N/A
  • EPS
  • WEAV N/A
  • DNTH N/A
  • Revenue
  • WEAV $212,950,000.00
  • DNTH $6,235,000.00
  • Revenue This Year
  • WEAV $17.08
  • DNTH N/A
  • Revenue Next Year
  • WEAV $15.39
  • DNTH N/A
  • P/E Ratio
  • WEAV N/A
  • DNTH N/A
  • Revenue Growth
  • WEAV 19.58
  • DNTH 120.63
  • 52 Week Low
  • WEAV $8.10
  • DNTH $13.37
  • 52 Week High
  • WEAV $17.63
  • DNTH $32.27
  • Technical
  • Relative Strength Index (RSI)
  • WEAV 50.92
  • DNTH 52.05
  • Support Level
  • WEAV $9.06
  • DNTH $20.76
  • Resistance Level
  • WEAV $10.99
  • DNTH $22.14
  • Average True Range (ATR)
  • WEAV 0.50
  • DNTH 1.55
  • MACD
  • WEAV 0.13
  • DNTH -0.04
  • Stochastic Oscillator
  • WEAV 76.13
  • DNTH 39.09

About WEAV Weave Communications Inc.

Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, it enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue primarily from subscription services.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: